Search hospitals > Texas > San Antonio
Clinical Trials of Texas, Inc
Claim this profileSan Antonio, Texas 78229
Global Leader in Healthy Subjects
Global Leader in Type 2 Diabetes
Conducts research for Diabetes
Conducts research for Nonalcoholic Steatohepatitis
Conducts research for Non-alcoholic Fatty Liver Disease
301 reported clinical trials
4 medical researchers
Summary
Clinical Trials of Texas, Inc is a medical facility located in San Antonio, Texas. This center is recognized for care of Healthy Subjects, Type 2 Diabetes, Diabetes, Nonalcoholic Steatohepatitis, Non-alcoholic Fatty Liver Disease and other specialties. Clinical Trials of Texas, Inc is involved with conducting 301 clinical trials across 367 conditions. There are 4 research doctors associated with this hospital, such as Pendleton Wickersham, MD, Douglas Scott Denham, Daniel Peterson, MD, and Alan Hand, MD.Top PIs
Pendleton Wickersham, MDSunpharma site no. 164 years of reported clinical research
Studies Psoriatic Arthritis
Studies Rheumatoid Arthritis
6 reported clinical trials
6 drugs studied
Douglas Scott DenhamClinical Trials of Texas, Inc.4 years of reported clinical research
Studies Obesity
Studies Childhood Obesity
4 reported clinical trials
5 drugs studied
Daniel Peterson, MDAustin Neurosurgeons7 years of reported clinical research
Studies Degenerative Disc Disease
Studies Spondylolisthesis
5 reported clinical trials
7 drugs studied
Alan Hand, MDWorldwide Clinical Trials2 years of reported clinical research
Studies Healthy Subjects
Studies Muscle Spasticity
3 reported clinical trials
3 drugs studied
Clinical Trials running at Clinical Trials of Texas, Inc
Liver Cancer
Major Depressive Disorder
Shingles
Liver Fibrosis
Alzheimer's Disease
Atherosclerosis
Cardiovascular Disease
Fatty Liver Disease
Obesity
Cerebral Amyloid Angiopathy
ALN-BCAT + Pembrolizumab
for Liver Cancer
The purpose of the dose escalation part of the study is to characterize the safety and tolerability of ALN-BCAT as monotherapy and in combination with pembrolizumab; and to determine the recommended dose(s) for expansion (RDFE) of ALN-BCAT as monotherapy and in combination with pembrolizumab. The purpose of the dose expansion part of the of the study is to evaluate the antitumor activity of ALN-BCAT as monotherapy and in combination with pembrolizumab; to characterize the safety and tolerability of ALN-BCAT as monotherapy and in combination with pembrolizumab.
Recruiting1 award Phase 14 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Clinical Trials of Texas, Inc?
Clinical Trials of Texas, Inc is a medical facility located in San Antonio, Texas. This center is recognized for care of Healthy Subjects, Type 2 Diabetes, Diabetes, Nonalcoholic Steatohepatitis, Non-alcoholic Fatty Liver Disease and other specialties. Clinical Trials of Texas, Inc is involved with conducting 301 clinical trials across 367 conditions. There are 4 research doctors associated with this hospital, such as Pendleton Wickersham, MD, Douglas Scott Denham, Daniel Peterson, MD, and Alan Hand, MD.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.